Javascript must be enabled to continue!
Brain and blood DNA methylation profiling in Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3)
View through CrossRef
Abstract
Background
Machado–Joseph disease (MJD) is a hereditary neurodegenerative disorder caused by an expanded CAG repeat in the
ATXN3
gene. Despite its monogenic origin, MJD presents heterogeneous clinical and neuropathological features that are only partially explained by genetic factors, suggesting a potential contribution of epigenetic modifiers. In this study, we profiled genome-wide DNA methylation in brain regions and peripheral blood from MJD mutation carriers at both preclinical and symptomatic stages.
Results
DNA methylation alterations in MJD brains were limited at the CpG level, with only three significant DMPs detected. In contrast, 175 DMRs were identified across the two brain regions analyzed, eight of which were shared between the DN and CC. While no specific biological pathways were enriched in the DN, hypermethylated regions in the relatively spared CC showed strong enrichment for myelination-related pathways. In peripheral blood, no genome-wide significant DMPs were detected, consistent with the lack of a distinct MJD episignature. Notably, methylation alterations in blood, detected as DMRs, were more pronounced in preclinical carriers. No blood DMRs were found to overlap with those identified in the brain. In blood samples of MJD patients, methylation levels of 5241 CpGs were associated with disease duration. Age acceleration was not associated with age at onset.
Conclusions
MJD exhibits subtle DNA methylation changes that occur primarily at genomic regions rather than individual CpG sites. In the brain, these alterations are largely region-specific, with the cerebral cortex showing enrichment for myelination-related pathways. In peripheral blood, exploratory analysis suggests that methylation changes are limited and do not mirror those observed in the brain. Together, these findings provide the first integrated analysis of the DNA methylation landscape in MJD across the brain and blood.
Title: Brain and blood DNA methylation profiling in Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3)
Description:
Abstract
Background
Machado–Joseph disease (MJD) is a hereditary neurodegenerative disorder caused by an expanded CAG repeat in the
ATXN3
gene.
Despite its monogenic origin, MJD presents heterogeneous clinical and neuropathological features that are only partially explained by genetic factors, suggesting a potential contribution of epigenetic modifiers.
In this study, we profiled genome-wide DNA methylation in brain regions and peripheral blood from MJD mutation carriers at both preclinical and symptomatic stages.
Results
DNA methylation alterations in MJD brains were limited at the CpG level, with only three significant DMPs detected.
In contrast, 175 DMRs were identified across the two brain regions analyzed, eight of which were shared between the DN and CC.
While no specific biological pathways were enriched in the DN, hypermethylated regions in the relatively spared CC showed strong enrichment for myelination-related pathways.
In peripheral blood, no genome-wide significant DMPs were detected, consistent with the lack of a distinct MJD episignature.
Notably, methylation alterations in blood, detected as DMRs, were more pronounced in preclinical carriers.
No blood DMRs were found to overlap with those identified in the brain.
In blood samples of MJD patients, methylation levels of 5241 CpGs were associated with disease duration.
Age acceleration was not associated with age at onset.
Conclusions
MJD exhibits subtle DNA methylation changes that occur primarily at genomic regions rather than individual CpG sites.
In the brain, these alterations are largely region-specific, with the cerebral cortex showing enrichment for myelination-related pathways.
In peripheral blood, exploratory analysis suggests that methylation changes are limited and do not mirror those observed in the brain.
Together, these findings provide the first integrated analysis of the DNA methylation landscape in MJD across the brain and blood.
Related Results
Effect of levodopa/carbidopa on the progression of Machado-Joseph disease /spinocerebellar ataxia type 3 (MJD/SCA3)
Effect of levodopa/carbidopa on the progression of Machado-Joseph disease /spinocerebellar ataxia type 3 (MJD/SCA3)
Background and Objectives
In Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3), ataxin-3 accumulates as neuronal nuclear inclusions in specific r...
Quantitative susceptibility mapping in spinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD)
Quantitative susceptibility mapping in spinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD)
Background
The deep nuclei, brainstem, and anterior central gyrus are important sites of spinocerebellar ataxia type3/Machado–Joseph Disease (SCA3/MJD) involvem...
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash
INTRODUCTION
The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
Magnetic Resonance Imaging and Its Clinical Correlation in Spinocerebellar Ataxia Type 3: A Systematic Review
Magnetic Resonance Imaging and Its Clinical Correlation in Spinocerebellar Ataxia Type 3: A Systematic Review
BackgroundSpinocerebellar ataxia type 3 (SCA3) is a complex cerebrocerebellar disease primarily characterized by ataxia symptoms alongside motor and cognitive impairments. The hete...
Research on Mitochondrial DNA Mutations in Patients with SCA3/MJD
Research on Mitochondrial DNA Mutations in Patients with SCA3/MJD
Abstract
Spinocerebellar ataxia type 3 (SCA3) is a degenerative neurological disorders caused by trinucleotide repeat expansion within the ataxin...
Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients
Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients
Machado-Joseph disease, or spinocerebellar ataxia type 3(MJD/SCA3), is the most frequent late onset spinocerebellar ataxia and results from a CAG repeat expansion in the ataxin-3 g...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis
Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis
ObjectivesTo perform a systematic review and meta-analysis of genetic risk factors for age at onset (AO) in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).MethodsT...

